ORIGINAL RESEARCH
Accepted on 03 Apr 2025
LINC01559 Drives Osimertinib Resistance in NSCLC Through a ceRNA Network Regulating miR-320a/IGF2BP3 Axis
doi 10.3389/fphar.2025.1592846
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Multi-omics Application in Exploring Potential Biomarkers Targeting Resistance of Anti-Cancer Drugs, Volume II
Multi-omics Application in Exploring Potential Biomarkers Targeting Resistance of Anti-Cancer Drugs, Volume II
409
Total downloads
2,139
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 18 Feb 2025
ASF1B promotes gastric cancer progression by modulating H2AC20 and activating PI3K/AKT and ERK1/2 pathways
doi 10.3389/fphar.2025.1533257
- 451 views
ORIGINAL RESEARCH
Published on 04 Feb 2025
TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response
doi 10.3389/fphar.2025.1517887
- 522 views
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: